Embolisation of pulmonary arteriovenous malformations using high-frequency jet ventilation: benefits of minimising respiratory motion.
Fiche publication
Date publication
juillet 2019
Journal
European radiology experimental
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin, Dr GARNON Julien
Tous les auteurs :
Boatta E, Cazzato RL, De Marini P, Canuet M, Garnon J, Heger B, Bernmann TM, Ramamurthy N, Jahn C, Lopez M, Gangi A
Lien Pubmed
Résumé
To evaluate patient radiation dose and procedural duration recorded during pulmonary arteriovenous malformation (PAVM) embolisation performed using high-frequency jet ventilation (HFJV) as compared with conventional intermittent positive pressure ventilation (IPPV) METHODS: Patients undergoing PAVM embolisation with HFJV assistance after April 2017 were retrospectively identified as group A, and those treated with IPPV before April 2017 as group B. Primary outcomes were patient radiation dose and procedural duration between groups A and B. Secondary outcomes were difference in diaphragmatic excursion between groups A and B, in group A with/without HFJ assistance, technical/clinical success, and complications.
Mots clés
Anesthesiology, Arteriovenous malformations, Embolisation (therapeutic), High-frequency jet ventilation, Lung
Référence
Eur Radiol Exp. 2019 Jul 9;3(1):26